Bank of America
TERN

Bank of America’s Terns Pharmaceuticals TERN Stock Holding History

Bank of America’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.8M Buy
811,636
+258,027
+47% +$10.6M ﹤0.01% 1711
2025
Q4 		$22.4M Sell
553,609
-151,164
-21% -$3.49M ﹤0.01% 2203
2025
Q3 		$5.29M Buy
704,773
+210,968
+43% +$1.35M ﹤0.01% 3946
2025
Q2 		$1.84M Sell
493,805
-318,237
-39% -$994K ﹤0.01% 4849
2025
Q1 		$2.24M Buy
812,042
+614,816
+312% +$2.51M ﹤0.01% 4586
2024
Q4 		$1.09M Buy
197,226
+138,661
+237% +$939K ﹤0.01% 4957
2024
Q3 		$488K Sell
58,565
-218,172
-79% -$1.8M ﹤0.01% 5497
2024
Q2 		$1.88M Buy
276,737
+238,373
+621% +$1.44M ﹤0.01% 4483
2024
Q1 		$252K Sell
38,364
-20,452
-35% -$134K ﹤0.01% 5772
2023
Q4 		$382K Buy
58,816
+30,993
+111% +$164K ﹤0.01% 5685
2023
Q3 		$140K Sell
27,823
-15,843
-36% -$101K ﹤0.01% 6097
2023
Q2 		$382K Sell
43,666
-4,285
-9% -$49.9K ﹤0.01% 5452
2023
Q1 		$568K Buy
47,951
+46,136
+2,542% +$441K ﹤0.01% 5303
2022
Q4 		$18.5K Sell
1,815
-5,911
-77% -$39.3K ﹤0.01% 6764
2022
Q3 		$46K Sell
7,726
-10,382
-57% -$38.6K ﹤0.01% 6713
2022
Q2 		$45K Buy
18,108
+10,884
+151% +$21.7K ﹤0.01% 6886
2022
Q1 		$21K Sell
7,224
-1,361
-16% -$5.81K ﹤0.01% 7503
2021
Q4 		$61K Buy
8,585
+3,453
+67% +$28.8K ﹤0.01% 7129
2021
Q3 		$53K Buy
5,132
+157
+3% +$1.63K ﹤0.01% 7019
2021
Q2 		$61K Sell
4,975
-4,512
-48% -$76.9K ﹤0.01% 6740
2021
Q1 		$208K Buy
+9,487
New +$208K ﹤0.01% 6008

Other funds holding TERN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Bank of America's TERN Position: Q1 2026 in Review

Bank of America increased its Terns Pharmaceuticals (TERN) stake by 47% in Q1 2026, buying an estimated $10.6M and bringing the position to 811,636 shares worth $42.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1711.

Bank of America first reported a position in TERN in Q1 2021 and has held it in 21 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Bank of America held 811,636 shares of Terns Pharmaceuticals worth $42.8M as of Q1 2026.
  • Bank of America bought 258,027 Terns Pharmaceuticals shares in Q1 2026, an estimated $10.6M.
  • Terns Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1711 holding.
  • Bank of America first reported a position in Terns Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.